EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieOpen Access · CC BY-NC 4.0

Primary Care Physician Use of Elastic Scattering Spectroscopy on Skin Lesions Suggestive of Skin Cancer

Stephen P Merry iD, Ivana T Croghan iD, Kimberly A Dukes iD, Brian C McCormick iD, Gerard T Considine iD, Michelle J Duvall, Curtis T Thompson iD, David J Leffell iD

Journal of Primary Care & Community Health · 2025

DOI: 10.1177/21501319251344423 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Primary Care & Community Health, 2025. Verfasst von Stephen P Merry und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Carcinoma, Squamous Cell, Melanoma, Physicians, Primary Care. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the performance of noninvasive, elastic scattering spectroscopy, algorithm-powered device (DermaSensor) to detect melanoma and basal and squamous cell cancers in the primary care setting. Patients & Methods: DERM-SUCCESS, a blinded, prospective, multicenter pivotal study, enrolled adult patients between August 17, 2020, and December 9, 2021, with lesions that their primary care physicians (PCPs) suspected of skin cancer at clinics in the US (n = 18) and Australia (n = 4). These lesions were assessed by PCPs and scanned with the DermaSensor device. Biopsy specimens were collected, and histopathologic analysis was performed by dermatopathologists. The diagnostic performance of the device, dermatopathologist discordance, and subgroup analyses of clinical interest were calculated.

Results

Of the 1579 skin lesions enrolled, dermatopathologic analysis identified 224 (14.2%) cancers. Device sensitivity was 95.5% (95% CI, 91.7%-97.6%) overall and 96.3% (92.9%-98.4%) for patients in the FDA-approved age group 40 years and older (90.2% for melanoma, 97.8% for basal cell carcinoma, and 97.7% for squamous cell carcinoma). Device specificity was 20.7%. The negative predictive value was 96.6%, and the positive predictive value was 16.6% (NNB 6). The device misclassified as “ monitor ” rather than “ investigate further ” 4 keratinocyte carcinomas and 4 melanomas in patients aged 40 years or older (n = 8, 0.5% of lesions, 3.7% of cancers biopsied).

Conclusions

The DermaSensor device is an easy-to-use, point-of-care, hand-held skin cancer adjunctive diagnostic device with high sensitivity and NPV to help inform PCP decision-making about skin lesions suspicious for cancer that need further evaluation and those that may be monitored.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basal Cell CarcinomaCarcinoma, Squamous CellMelanomaPhysicians, Primary CareSkin NeoplasmsSpectrum AnalysisAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedAlgorithmsAustraliaPrimary Health CareProspective StudiesSensitivity and Specificity

Stichwörter der Autor:innen

DermaSensorbasal cell carcinomaelastic scattering spectroscopymelanomaprimary careskin cancersquamous cell carcinoma

Autor:innen und Institutionen

  • Department of Family Medicine, Mayo Clinic, Rochester, MN, USA.
  • Department of Internal Medicine, Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
  • Hampton Family Practice, Hampton, VA, USA.
  • Clare Medical Centre, Clare, SA, Australia.
  • Department of Dermatology and Department of Pathology, Oregon Health & Science University, Portland, Oregon, USA; CTA Pathology: Curtis Thompson, MD & Associates, Beaverton, OR, USA.

ORCID-Profile: Stephen P Merry, Ivana T Croghan, Kimberly A Dukes, Brian C McCormick, Gerard T Considine, Curtis T Thompson, David J Leffell

Zitieren

APA

Merry, S. P., Croghan, I. T., Dukes, K. A., McCormick, B. C., Considine, G. T., Duvall, M. J., Thompson, C. T., & Leffell, D. J. (2025). Primary Care Physician Use of Elastic Scattering Spectroscopy on Skin Lesions Suggestive of Skin Cancer. Journal of Primary Care & Community Health. https://doi.org/10.1177/21501319251344423

Vancouver

Merry SP, Croghan IT, Dukes KA, McCormick BC, Considine GT, Duvall MJ, et al. Primary Care Physician Use of Elastic Scattering Spectroscopy on Skin Lesions Suggestive of Skin Cancer. Journal of Primary Care & Community Health. 2025. doi:10.1177/21501319251344423

BibTeX
@article{Merry2025,
  author = {Merry, Stephen P and Croghan, Ivana T and Dukes, Kimberly A and McCormick, Brian C and Considine, Gerard T and Duvall, Michelle J and Thompson, Curtis T and Leffell, David J},
  title = {Primary Care Physician Use of Elastic Scattering Spectroscopy on Skin Lesions Suggestive of Skin Cancer},
  journal = {Journal of Primary Care & Community Health},
  year = {2025},
  doi = {10.1177/21501319251344423}
}
Kostenlos starten →